Cpl Life Sciences is proud to be attending the World Drug Safety Congress Europe, where leaders in drug safety, pharmacovigilance, data analytics, epidemiology, and the broader biopharma sector will come together to shape the future of patient safety. This premier event offers a unique opportunity to explore the transformative role of big data and AI in pharmacovigilance, delve into benefit-risk management strategies, and embrace patient-centric approaches.
Attendees will also tackle pressing global challenges, including the impact of social media on drug safety and evolving international legislation. The congress serves as a vital bridge between regulatory authorities, industry experts, and academic voices, driving forward innovation and collaboration in pharmacovigilance operations.
For more information on the event click here
